GlassScriptPhysician profile
Mark Nicolau
NPI 1164787834
$12,492.16
in general payments reported to CMS, 2019-2025
15 companies · $1,334 in 2025
The $1,334 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,417 · 2020: $71.12 · 2021: $156 · 2022: $329 · 2023: $2,035 · 2024: $150 · 2025: $1,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,750 · Food and Beverage: $1,160 · Travel and Lodging: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,750.00 |
| Food and Beverage | $1,159.73 |
| Travel and Lodging | $608.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,638.70 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $1,510.65 | 2019-2024 | Phasix Mesh |
| Medtronic, INC. | $368.60 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $308.54 | 2019 | |
| Kci USA, INC. | $142.81 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $107.58 | 2019-2023 | Clenpiq |
| Boston Scientific Corporation | $95.89 | 2023 | Spyscope Ds, Spyglass Discover |
| Braintree Laboratories, INC. | $89.67 | 2021-2022 | |
| Becton, Dickinson and Company | $77.93 | 2025 | Arista |
| Bioventus LLC | $47.90 | 2021 | |
| Conmed Corporation | $31.86 | 2022-2024 | Airseal |
| Redhill Biopharma INC. | $22.98 | 2021 | |
| Olympus America INC. | $16.70 | 2020 | |
| Ethicon US, LLC | $16.26 | 2021 | |
| Omeros Corporation | $16.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Nicolau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.